Cash allocation. No separate rationale was supplied.

I expect Allstate to contribute satisfactory long-term returns because its reported 5.04 P/E leaves a wider valuation cushion than most holdings, while the 2.90% 20-session decline avoids paying for excitement. I'm wrong if subsequent earnings do not support that low multiple; I exit if the discount loses its margin of safety.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect Bristol Myers Squibb to provide patient total return because its 13.51 P/E and 3.99% trailing cash dividend yield leave some valuation support after a 7.06% 20-session decline. I'm wrong if earnings fail to sustain the valuation; I exit if the income cushion and discount cease to compensate for the uncertainty.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect Cigna to compound acceptably because its 10.94 P/E and 2.24% trailing dividend yield provide a restrained entry point, despite a modest 0.52% 20-session decline. I'm wrong if earnings no longer justify the valuation; I exit if the apparent discount is removed without improved underlying support.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect EOG Resources to reward patience because the supplied 10.38 P/E, 2.80% dividend yield, and 2.68% recent decline offer a reasonable cushion for an energy allocation. I'm wrong if reported earnings prove too weak for the multiple; I exit if valuation support erodes materially.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect Honeywell's valuation to be recognized over time because its reported 9.47 P/E is unusually restrained within this list, and the 6.87% 20-session fall supplies a less enthusiastic entry. I'm wrong if earnings weaken enough to invalidate the multiple; I exit if the discount no longer offers a credible margin of safety.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect Accenture to offer measured upside because its reported 15.20 P/E and 3.43% trailing dividend yield are reasonable for a diversified technology allocation, without relying on a dramatic recent move. I'm wrong if earnings do not sustain this valuation; I exit if the modest margin of safety disappears.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect Altria to deliver useful total return primarily from its 6.15% trailing dividend yield alongside a 12.70 P/E, rather than from an exciting growth narrative. I'm wrong if the business transition risk overwhelms cash returns, as the supplied commentary notes; I exit if earnings no longer support the income case.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect Wells Fargo to compound steadily because its 12.67 P/E and 2.13% trailing dividend yield provide a conventional value anchor, with only a 1.11% 20-session gain. I'm wrong if earnings do not support the multiple; I exit if valuation becomes less restrained without a corresponding improvement in evidence.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect Aflac to provide a quiet financials allocation because its 14.95 P/E, 2.07% trailing dividend yield, and essentially flat 20-session return indicate limited recent enthusiasm. I'm wrong if earnings weaken enough to impair the valuation case; I exit if the modest discount ceases to offer downside protection.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect Intuit to offer a patient re-entry opportunity because its 12.44 P/E follows a sharp 13.61% 20-session decline, creating a more useful valuation cushion than momentum provides. The 1.53% trailing dividend yield adds modest support. I'm wrong if earnings do not sustain the multiple; I exit if the decline reflects lasting impairment.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect PepsiCo to provide a defensive total-return component because its 4.34% trailing dividend yield and 6.26% 20-session decline offer a calmer entry than recent sentiment suggests. I'm wrong if earnings cannot justify its 19.95 P/E; I exit if the dividend support no longer offsets that fuller valuation.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect Chubb to add balance through a restrained 14.54 P/E and a nearly flat 0.29% 20-session return, avoiding a purchase driven by price excitement. Its 1.16% trailing dividend yield is supplementary rather than the thesis. I'm wrong if earnings no longer support the multiple; I exit if valuation discipline is lost.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

Exit Progressive to reduce insurance concentration and fund INTU. Although PGR reports a 10.64 P/E and 6.43% yield, supplied commentary judges valuation fair-to-slightly elevated and advises value investors to wait, leaving less margin of safety than the replacement.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: weeks